HTUPG
Mark Identification

HTUPG

Serial Number

88258856

Filing Date

Jan 11, 2019

Trademark by

HARBIN MEDISAN PHARMACEUTICAL CO. LTD.

Classification Information

Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pain relief medication; Medicines for the treatment of gastrointestinal diseases; Anti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Protein arrays for diagnosing allergies, and cancer; Therapeutic pharmaceutical for the treatment of gastrointestinal, cancer, infection, neurological, cardiovascular, musculoskeletal and immune system related diseases and disorders; Pharmaceutical preparations, namely, elixirs for the treatment of gastrointestinal, cancer, infection, neurological, cardiovascular, musculoskeletal and immune system related diseases and disorders; Pharmaceutical preparations for the treatment and prevention of gastrointestinal, cancer, infection, neurological, cardiovascular, musculoskeletal and immune system related diseases and disorders; Nutritional supplements in the form of capsules, tablets, caplets, powder, syrups, gummies and gels; Dietary and nutritional supplements; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets; Dietetic foods for treating celiac disease and gastrointestinal disorders; Chemical preparations for pharmaceutical or medical purposes, namely, for treatment and prevention of gastrointestinal, cancer, infection, neurological, cardiovascular, musculoskeletal and immune system related diseases and disorders; Capsules made from starch sold empty for pharmaceuticals; Biometallic compounds being a component in pharmaceutical preparations for treatment and prevention of gastrointestinal, cancer, infection, neurological, cardiovascular, musculoskeletal and immune system related diseases and disorders; Biological preparations for the treatment and prevention of gastrointestinal, cancer, infection, neurological, cardiovascular, musculoskeletal and immune system related diseases and disorders; Transdermal patches for use in the treatment of musculoskeletal diseases; Specialized tablets, capsules and powders for the delivery of pharmaceuticals sold without the pharmaceutical ingredient; Tumor suppressing agents; Nutraceuticals for the treatment of cardiovascular diseases and disorders

Pharmaceuticals